MicroRNAs and atherosclerosis: New actors for an old movie

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 11, 2012, Pages 937-943

  Santovito, D ^a   Mezzetti, A ^a   Cipollone, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerosis; Cardiovascular disease; MicroRNA; Stroke; Unstable plaque

Indexed keywords

MICRORNA;

ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW; RNA PROCESSING;

ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MYOCARDIUM; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84868352089     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.03.007     Document Type: Review

References (81)

1. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
2. Nana-Sinkam S.P., Croce C.M. MicroRNAs as therapeutic targets in cancer. Transl Res 2011, 157:216-225.
3. Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R. Diabetes mellitus, a microRNA-related disease?. Transl Res 2011, 157:253-264.
4. Kerr T.A., Korenblat K.M., Davidson N.O. MicroRNAs and liver disease. Transl Res 2011, 157:241-252.
5. Dai R., Ahmed S.A. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 2011, 157:163-179.
6. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
7. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
8. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
9. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016.
10. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
11. Okamura K., Hagen J.W., Duan H., Tyler D.M., Lai E.C. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 2007, 130:89-100.
12. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
13. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS Biol 2005, 3:e85.
14. Hutvagner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
15. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
16. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006, 20:515-524.
17. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
18. Hwang H.W., Wentzel E.A., Mendell J.T. A hexanucleotide element directs microRNA nuclear import. Science 2007, 315:97-100.
19. Kim D.H., Saetrom P., Snove O., Rossi J.J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A 2008, 105:16230-16235.
20. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
21. Place R.F., Li L.-C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 2008, 105:1608-1613.
22. Orom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008, 30:460-471.
23. Lee E.J., Baek M., Gusev Y., Brackett D.J., Nuovo G.J., Schmittgen T.D. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 2008, 14:35-42.
24. Michael M.Z., van Holst Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
25. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
26. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400.
27. Yousef M., Showe L., Showe M. A study of microRNAs in silico and in vivo: bioinformatics approaches to microRNA discovery and target identification. FEBS J 2009, 276:2150-2156.
28. Latronico M.V.G., Catalucci D., Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res 2007, 101:1225-1236.
29. Ikeda S., Kong S.W., Lu J., Bisping E., Zhang H., Allen P.D., et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007, 31:367-373.
30. Rao P.K., Toyama Y., Chiang H.R., Gupta S., Bauer M., Medvid R., et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 2009, 105:585-594.
31. Yang W.J., Yang D.D., Na S., Sandusky G.E., Zhang Q., Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005, 280:9330-9335.
32. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588.
33. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American heart association. Circulation 2011, 123:e18-e209.
34. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
35. Kuehbacher A., Urbich C., Zeiher A.M., Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007, 101:59-68.
36. Harris T.A., Yamakuchi M., Ferlito M., Mendell J.T., Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 2008, 105:1516-1521.
37. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010, 107:810-817.
38. Harris T.A., Yamakuchi M., Kondo M., Oettgen P., Lowenstein C.J. Ets-1 and ets-2 regulate the expression of microRNA-126 in endothelial cells. Arterioscler Thromb Vasc Biol 2010, 30:1990-1997.
39. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009, 2:ra81.
40. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
41. Suárez Y., Fernández-Hernando C., Pober J.S., Sessa W.C. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007, 100:1164-1173.
42. Zhu N., Zhang D., Chen S., Liu X., Lin L., Huang X., et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 2011, 215:286-293.
43. Li D., Yang P., Xiong Q., Song X., Yang X., Liu L., et al. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J Hypertens 2010, 28:1646-1654.
44. Vaughan D.E. At(1) receptor blockade and atherosclerosis: hopeful insights into vascular protection. Circulation 2000, 101:1496-1497.
45. Martin M.M., Lee E.J., Buckenberger J.A., Schmittgen T.D., Elton T.S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 2006, 281:18277-18284.
46. Martin M.M., Buckenberger J.A., Jiang J., Malana G.E., Nuovo G.J., Chotani M., et al. The human angiotensin II type 1 receptor +1166 a/c polymorphism attenuates microRNA-155 binding. J Biol Chem 2007, 282:24262-24269.
47. Fang Y., Shi C., Manduchi E., Civelek M., Davies P.F. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A 2010, 107:13450-13455.
48. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., et al. MicroRNA-21 contributes to myocardial disease by stimulating map kinase signalling in fibroblasts. Nature 2008, 456:980-984.
49. Zhong X., Chung A.C., Chen H.Y., Meng X.M., Lan H.Y. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011, 22:1668-1681.
50. Weber M., Baker M.B., Moore J.P., Searles C.D. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 2010, 393:643-648.
51. Fleissner F., Jazbutyte V., Fiedler J., Gupta S.K., Yin X., Xu Q., et al. Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ Res 2010, 107:138-143.
52. Forrest A.R., Kanamori-Katayama M., Tomaru Y., Lassmann T., Ninomiya N., Takahashi Y., et al. Induction of microRNAs, miR-155, miR-222, miR-424 and miR-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 2010, 24:460-466.
53. Chen T., Huang Z., Wang L., Wang Y., Wu F., Meng S., et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 2009, 83:131-139.
54. Huang R.S., Hu G.Q., Lin B., Lin Z.Y., Sun C.C. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med 2010, 58:961-967.
55. Navab M., Reddy S.T., Van Lenten B.J., Fogelman A.M. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 2011, 8:222-232.
56. Rayner K.J., Suarez Y., Davalos A., Parathath S., Fitzgerald M.L., Tamehiro N., et al. miR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
57. Ramirez C.M., Davalos A., Goedeke L., Salerno A.G., Warrier N., Cirera-Salinas D., et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 2011, 31:2707-2714.
58. Rayner K.J., Sheedy F.J., Esau C.C., Hussain F.N., Temel R.E., Parathath S., et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 2011, 121:2921-2931.
59. Leeper N.J., Raiesdana A., Kojima Y., Chun H.J., Azuma J., Maegdefessel L., et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011, 226:1035-1043.
60. Cheng Y., Liu X., Yang J., Lin Y., Xu D.-Z., Lu Q., et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009, 105:158-166.
61. Torella D., Iaconetti C., Catalucci D., Ellison G.M., Leone A., Waring C.D., et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011, 109:880-893.
62. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
63. Xin M., Small E.M., Sutherland L.B., Qi X., McAnally J., Plato C.F., et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009, 23:2166-2178.
64. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009, 284:3728-3738.
65. Minami Y., Satoh M., Maesawa C., Takahashi Y., Tabuchi T., Itoh T., et al. Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest 2009, 39:359-367.
66. Cipollone F., Felicioni L., Sarzani R., Ucchino S., Spigonardo F., Mandolini C., et al. A unique microRNA signature associated with plaque instability in humans. Stroke 2011, 42:2556-2563.
67. Raitoharju E., Lyytikainen L.P., Levula M., Oksala N., Mennander A., Tarkka M., et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere vascular study. Atherosclerosis 2011, 219:211-217.
68. Boettger T., Beetz N., Kostin S., Schneider J., Krüger M., Hein L., et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the miR143/145 gene cluster. J Clin Invest 2009, 119:2634-2647.
69. Castoldi G., Di Gioia C.R., Bombardi C., Catalucci D., Corradi B., Gualazzi M.G., et al. MiR-133a regulates collagen 1a1: potential role of miR-133a in myocardial fibrosis in angiotensin II dependent hypertension. J Cell Physiol 2012, 227:850-856.
70. Liu Y., Taylor N.E., Lu L., Usa K., Cowley A.W., Ferreri N.R., et al. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 2010, 55:974-982.
71. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J.J., et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of e-box repressors. Proc Natl Acad Sci U S A 2007, 104:3432-3437.
72. Cipollone F., Fazia M., Mezzetti A. Novel determinants of plaque instability. J Thromb Haemost 2005, 3:1962-1975.
73. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappab-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103:12481-12486.
74. Yamasaki K., Nakasa T., Miyaki S., Ishikawa M., Deie M., Adachi N., et al. Expression of microRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009, 60:1035-1041.
75. Mishra P.K., Tyagi N., Kumar M., Tyagi S.C. MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med 2009, 13:778-789.
76. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., Wythe J.D., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008, 15:272-284.
77. Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-a3. J Biol Chem 2008, 283:15878-15883.
78. Chen Y., Gorski D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008, 111:1217-1226.
79. Lee D.Y., Deng Z., Wang C.H., Yang B.B. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 2007, 104:20350-20355.
80. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006, 38:1060-1065.
81. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.